non-targeting control gRNA (BRDN0001147797) Citations (1)

Originally described in: Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9.
Doench JG, Fusi N, Sullender M, Hegde M, Vaimberg EW, Donovan KF, Smith I, Tothova Z, Wilen C, Orchard R, Virgin HW, Listgarten J, Root DE Nat Biotechnol. 2016 Jan 18. doi: 10.1038/nbt.3437. PubMed Journal

---

Articles Citing non-targeting control gRNA (BRDN0001147797)

Articles
Epigenetic Regulation of Fanconi Anemia Genes Implicates PRMT5 Blockage as a Strategy for Tumor Chemosensitization. Du C, Li SW, Singh SX, Roso K, Sun MA, Pirozzi CJ, Yang R, Li JL, He Y. Mol Cancer Res. 2021 Dec;19(12):2046-2056. doi: 10.1158/1541-7786.MCR-21-0093. Epub 2021 Sep 14. PubMed

If you have published an article using this material, please email us at to have your article added to this page.